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on pain, walking ability, and muscle function in patients
with knee osteoarthritis
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Department of Exercise Prescription & Rehabilitation, Dankook University, Cheonan, Korea
Department of Physical and Rehabilitation Medicine, Samsung Medical Center, Seoul, Korea
3
Department of Counseling, Health, and Kinesiology, Texas A&M University-San Antonio, San Antonio, TX, USA
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The purpose of this study was to investigate the short-term of Theracurmin dose and exercise type on pain, walking ability, and muscle
function in patients with knee osteoarthritis. Twenty-five patients with
knee osteoarthritis randomly selected to Theracurmin intake (T) group
and Theracurmin in combined with exercise (T+E) group. T group
(n= 13) was taken orally a capsule of 700 mg, 3 times per day, (total 2,100
mg, 35 mg/kg-body weight). T+E group (n= 12) performed aerobic training of 30-min walking and weight training for increasing leg muscular
strength. After treatment, the number of steps, muscle mass, range of
motion of knee, and the muscle strength in flexion and extension significantly increased. The percent body fat, visual analogue scale, The
Western Ontario and McMaster score, centers of pressure with closed

eye, 10-m walking ability, stair ascending speed were significantly decreased after treatment. Although no difference observed between the
T and T+E groups, the 4-week intake of Theracurmin with and without
exercise appeared to be effective in reducing the pain and enhancing
muscular and balancing function. Therefore, Theracurmin intake for
early symptoms and additional exercise as symptoms alleviate might be
an effective way of delaying and managing osteoarthritis, and additional studies investigating the effects of Theracurmin and exercise on osteoarthritis could be beneficial.
Keywords: Theracurmin, Exercise, Pain, Walking ability, Knee osteoarthritis

INTRODUCTION

joint deterioration, and gait deviation (Franklin et al., 2008; Guccione et al., 1994). Osteoarthritis mainly causes pain due to loss and
degeneration of cartilage tissue that functions to prevent friction
and absorb impact (Davies et al., 2008). Loss and degeneration of
cartilage tissue thus results in a decrease in walking speed and
knee joint working range and limits daily living function. These
changes eventually lead to diminished muscular strength and balance control from weakened muscles surrounding the knee joint
(Hong, 2007). Therefore, rehabilitation treatment programs for
osteoarthritis patients must be a combination of methods that decrease pain and stress on the joint and improve muscular function.
Most previous studies reported that aerobic exercises like walking and weight training (for strengthening the quadriceps femoris

Osteoarthritis, also known as degenerative joint disease, gradually destroys the joints over time. The biochemical cause of osteoarthritis is still not entirely clear, but it has been reported that
matrix metalloproteinases (MMPs) are involved in the degradation process of cartilage tissue. MMPs are excessively generated
when the joint structure is abnormal or when an abnormally strong
mechanical or biochemical stimulus acts on the articular cartilage
tissue (Henrotin et al., 2002).
Osteoarthritis is more likely to occur with increasing age (Cross
et al., 2014; Felson et al., 2000). Patients with osteoarthritis suffer
from symptoms such as joint pain, decreased daily living function,
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muscle) are effective in decreasing pain and improving muscular
function (Jordan et al., 2003; Roddy et al., 2005). Osteoarthritis is
most common in the knee joint. Osteoarthritis involves inflammation and decreased function of not only the cartilage of the knee but
also the muscles, tendons, ligaments, and synovia of the knee; therefore, it is challenging for osteoarthritis patients to perform the training treatment without pain management (Aigner et al., 2006).
Pain is caused by direct stimulation of pain receptors that triggers an inflammation mediator or by secondary inflammation
from biochemical or autoimmune responses. Therefore, the most
common treatment for decreasing the pain of osteoarthritis has
been the administration of analgesic and nonsteroidal anti-inflammatory drugs. However, these drugs can cause severe gastrointestinal and cardiovascular adverse events with long-term use (Felson
et al., 2000), and disease modifying agents that not only decrease
the pain but also delay the progression of osteoarthritis would be
beneficial.
Curcumin is a yellow polyphenolic spice extracted from rhizomes
of curcuma long a linn, a plant classified as in the ginger family
and mainly used for cooking foods like curries. Recently it has
been shown to have anti-inflammatory and antioxidative properties according to many studies (Goel et al., 2008; Vogel and Pelletier, 1815). It reported that curcumin regulates biochemical
molecular mechanisms by controlling various molecular targets
such as transcription factors, cytokines, and enzymes (Gupta et al.,
2012). These effects of curcumin are reported to be effective for
diseases related to chronic inflammation such as cardiovascular
disease, metabolic syndromes, osteoarthritis, and other aging related diseases (Goel et al., 2008; Gupta et al., 2012; Wongcharoen
and Phrommintikul, 2009). Curcumin has also been reported to
regulate osteoarthritis without any gastrointestinal adverse effects
(Mobasheri et al., 2012).
Despite the many reports on the beneficial effects of curcumin,
it has low bioavailability when taken orally and has a short halflife. Therefore, a limited number of studies shows effects of oral
curcumin taken by human subjects. Accordingly, a drug called
Theracurmin recently developed with the physiologic activity of
curcumin increased by 27 times, and it was reported that the pain
of osteoarthritis patients significantly decreased after taking Theracurmin for 8 weeks (Nakagawa et al., 2014). However, the studies on the effects of Theracurmin intake have yet to show consistent results of significantly decreased pain or other significant improvements (Akazawa et al., 2012; Mathy-Hartert et al., 2009;
Nakagawa et al., 2014). In addition, although previous studies
involving treatment with Curcumin have demonstrated positive
https://doi.org/10.12965/jer.1735064.532

effects in decreasing pain, there have been no studies demonstrating an increase in functional capability. A study needs to be done
demonstrating the effects of curcumin in conjunction with exercise, which is the suggested rehabilitation treatment program for
osteoarthritis patients.
Therefore, this study was to investigate the effects of Theracurmin (Kyungdong market, Seoul, Korea) intake for reducing pain
in conjunction with rehabilitation training for osteoarthritis affects pain and muscular function of osteoarthritis patients.

MATERIALS AND METHODS
Subjects
Osteoarthritis patients with knee pain who visited Dream Hanmaum Rehabilitation Medicine located in Seoul, selected 25 patients satisfied the clinical and radiologic diagnostic criteria for
knee joint osteoarthritis proposed by the Rheumatic Society (Altman, 1991), and also satisfied the criteria for second to third degree involvement on the Kellgren-Lawrence magnitude scale on
more than one knee. The study was approved by the Institutional
Ethnics Committee of Physical Education of the Dankook University (2015-05-001). Written informed consent obtained from
all subjects. Patients with under drug treatment for other diseases,
history of drug hypersensitivity reactions, and a swelling on their
knee excluded from this study. All the selected patients were to
provide informed consent before the start of the study. The final
selected subjects randomly split into two groups (Theracurmin
intake group, T group; Theracurmin with exercise group, T+E
group) (Table 1). In addition, because changes in physical activity
can affect the treatment, all subjects given a step-measuring instrument so that they could record daily steps during the treatment period in addition to the exercise time. Changes in the
number of steps described in Fig. 1. The number of steps during
the treatment period significantly increased (F=4.713, P<0.05),
with a tendency of correlation effect between the treatment and
Table 1. Baseline demographic of the knee osteoarthritis patients according to
the treatment
Variable
Age (yr)
Duration of knee pain (mo)
Site of knee
Right:left
Grade

T (n= 13)

T+E (n= 12)

Sig

44.77± 5.38
3.31± 1.18

40.58± 7.71
4.08± 1.38

-1.583 0.127
-1.191 0.246

6:7
1.69± 0.63

8:4
1.41± 0.52

1.118 0.275

Values are presented as mean± standard deviation or number.
T, Theracurmin intake group; T+E, Theracurmin with exercise group.
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Fig. 1. The changes of steps during treatment. T, Theracurmin intake; T+E, Theracurmin with exercise.

the groups (F=4.333, P=0.051), but there was no difference between the two groups.
Body composition measurement
Every subject underwent anthropometric examination while
wearing light clothes; data regarding medical history also collected. Body weight (BW) and body fat percentage measured using
InBody (Inbody 4.5, Biospace, Seoul, Korea), and body mass index (BMI) calculated as weight (kg) divided by height (m).
Pain test
Degree of pain for osteoarthritis patients was measured using a
visual analogue scale (VAS), A translated contents of The Western
Ontario and McMaster Universities Osteoarthritis index (WOMAC-VA3.0) verified by Yi et al. (2008) and Bellamy (1988) were
used for this study. The survey included three major sections on
pain, joint stiffness, and difficulty in physical function. The pain
section had five questions, the joint stiffness section had two questions, and the difficulty in physical function section had 17 questions total. The questionnaire administered by a trained physical
therapist after a face-to-face interview.
Range of motion of knee test
Knee joint flexion angle measured with the patient lying down
on the examination table with the leg flexed and bent voluntarily
as much as possible at both, the right and left knee using a goniometer. Knee joint extension angle measured with the patient lying with his/her face down on the examination table with a pillow
underneath the thigh and the knee joint extended on both, the
right and left knee using a goniometer.
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Balance test
The balance test involved examining the patient’s performance
while standing on one leg under both conditions: centers of pressure (COP) with the eyes open and eyes closed, and the performance in the balance wobble test when standing. The durations
for which the patient stood on one leg with the eyes open and eyes
closed were measured in seconds, and the duration was considered
till the time the lifted foot touched the ground or when the maintaining foot moved more than twice. The balance wobble test applied while standing used to analyze the degree to which the patient’s balance shook, in millimeters, when he/she stood on the
balance disk and when he/she stood on one leg.
Walking ability test
The 10-m walking test and going up and down stairs that are
similar to the daily activity of osteoarthritis patients performed as
walking ability test. The 10-m walking test measured as the time
in seconds that the subjects wearing comfortable shoes took to walk
10 m as fast as possible after the “start” sign. In addition, a ground
reaction plate installed on the 10 m straight course for measuring
the weight loaded on the pelvis. Walking up and down stairs measured as the time in seconds the subjects took when walking up and
down 10 stairs of 1.6-cm height in a row without running.
Isokinetic strength test
Peak torque, total work, and average power of thigh measured
using an isokinetic training instrument called Biodex (Biodex
B-2000, Biodex Medical Systems Inc., Shirley, NY, USA). Subjects were performed the procedure by repeating the warm-up exercise five times so that they could exhibit their maximum capacity. Gravity effect torque measured and analyzed to rule out the effect coming from the weight of the leg. Subjects sat on a flat chair
seat, placed the knee joint axis parallel to the dynamometer axis,
and fixed their upper body with a torso belt and seat belt to minimize interference except for the quadriceps femoris muscle. The
test repeated 5 times at 60°/sec to measure the maximum muscular strength and the total work amount, and the subjects were encouraged to demonstrate their maximum ability.
Curcumin intake method
Curcumin intake was recommended to be ingested within the
approved range of dosage by the Food and Drug Administration
as “Generally Regarded As Safe” (0.1–3 mg/kg-BW, clinical development plan) (Chemoprevention Branch and Agent Development Committee, 1996). However, preliminary studies and dis-
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cussions suggested that this dosage might be too low for physiologic activity due to low intestinal absorption and short half-life
of curcumin (Anand et al., 2007; Shoba et al., 1998). Other studies suggested a dosage of up to 12 g/day is safe for humans (Anand
et al., 2007), with no side effects when 180 mg of Theracurmin
was taken per day for 8 weeks (Nakagawa et al., 2014). Therefore,
a capsule of 700 mg was taken orally 3 times per day, (total 2,100
mg, 35 mg/kg-BW) (for a limited period of four weeks because of
its high dosage) after consultation with experts.
Exercise training program
The exercise training program consisted of aerobic training of
30-min walking and weight training for increasing leg muscular
strength. Aerobic exercise started at 15 min on the first week; thereafter, it increased by 5 min every week so that in the last week,
walking time reached 30 min. Weight training is composed of
the movements for strengthening major muscles for the knee joint
such as quadriceps femoris muscle, hamstrings, and triceps muscle of calf muscle (Han and Bang, 1994). Stretching, pressing down
on the knee with a towel, tightening the towel, and gym ball squats
carried out 8–10 times each, 2 sets total, and 3 times per week
during the adaptation period of the first 2 weeks. During the improvement period (3 and 4 weeks), squats on a chair, kicks on a
chair, and standing on heels on a chair were performed again 8–10
times each, 2 sets total, and 3 times per week.
Statistical analysis
The statistical analyses performed using IBM SPSS ver. 18.0

Group

Weight (kg)

T
T+E

Pre

Post

61.98± 5.28 61.91± 4.93
62.61± 6.45 62.45± 6.56

Muscle mass (kg)

T
T+E

21.01± 2.24 21.68± 1.31
21.84± 2.42 22.19± 2.40

%Fat (%)

T
T+E

37.69± 5.19 35.47± 3.24
35.62± 3.70 34.45± 3.60

Body mass index
(kg/m2)

T
T+E

25.55± 2.11 25.62± 1.96
25.31± 2.67 25.23± 2.80

Values are presented as mean± standard deviation.
T, Theracurmin intake; T+E, Theracurmin with exercise.
*P< 0.05.
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Table 3. The changes of pain score after treatment
Variable

Group

Pre

Post

T
T+E

4.42± 1.16
5.00± 1.87

2.75± 1.76
3.08± 2.36

Time 0.000***
Group 0.474
T× G 0.751

T
T+E

5.25± 2.18
6.38± 3.43

3.17± 2.41
3.54± 3.26

Joint stiffness

T
T+E

2.25± 1.28
3.15± 1.95

2.25± 1.48
34.45± 1.72

Physical function

T
T+E

17.42± 7.76 13.67± 9.49
23.15± 13.05 14.54± 10.87

Total

T
T+E

24.92± 10.21 19.08± 12.38
32.69± 17.44 20.23± 14.48

Time
Group
T× G
Time
Group
T× G
Time
Group
T× G
Time
Group

0.000***
0.477
0.455
0.239
0.437
0.239
0.002**
0.400
0.174
0.001**
0.391

T× G

0.163

VAS (score)

WOMAC (score)
Pain

Table 4. The changes of range of motion of knee after treatment
More-pain site
Flextion (°)

Sig
Time
Group
T× G
Time
Group
T× G
Time
Group
T× G
Time
Group
T× G

0.601
0.806
0.848
0.049*
0.424
0.531
0.045*
0.275
0.520
0.958
0.748
0.463

Sig

Values are presented as mean± standard deviation.
VAS, visual analogue scale; WOMAC, Western Ontario and MacMaster; T, Theracurmin intake; T+E, Theracurmin with exercise.
**P< 0.01. ***P< 0.001.

Variable

Table 2. The changes of body composition after treatment
Variable

(IBM Co., Armonk, NY, USA). The data expressed as average and
the standard deviation for each group. A two-way analysis of variance with repeated measures performed to verify the effect of the
time and treatment. The statistically significant level (α) for all
analysis was 0.05.

Extension (°)

Less-pain site
Flextion (°)

Extension (°)

Group

Pre

Post

T
T+E

130.42± 6.45 135.58± 8.46
127.00± 8.79 134.00± 7.48

T
T+E

-11.08± 2.50
-10.85± 3.58

T
T+E

131.50± 5.99 138.42± 5.03
126.77± 8.70 135.15± 11.01

T
T+E

-12.83± 3.61
-11.54± 2.15

-9.50± 1.88
-8.69± 3.40

-10.33± 2.35
-8.15± 2.91

Sig
Time
Group
T× G
Time
Group
T× G

0.000***
0.398
0.458
0.001**
0.629
0.580

Time
Group
T× G
Time
Group
T× G

0.000***
0.104
0.517
0.000***
0.086
0.443

Values are presented as mean± standard deviation.
T, Theracurmin intake; T+E, Theracurmin with exercise.
**P< 0.01. ***P< 0.001.
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Table 6. The changes of walking after treatment

RESULTS

Variable

The changes in body composition
Table 2 shows the changes in body composition after 4 weeks of
Theracurmin and exercise. BW and BMI were not significantly
different. Muscle mass was significantly increased (P<0.05), and
the percent body fat was significantly decreased (P<0.05) after
treatment. There was no correlation between time and group.

10-M walking
Speed (sec)

Gravity (N)

Group

Pre

T
T+E

7.42± 0.74
7.04± 0.75

Descending (sec)

Sig

6.72± 0.76 Time 0.000***
6.509± 0.80 Group 0.309
T× G 0.478
618.17± 50.81 610.50± 61.58 Time 0.008**
628.77± 67.60 602.38± 65.13 Group 0.959
T× G 0.126

T
T+E

Stair ascending & descending
Ascending (sec)
T
T+E

The changes in pain score
Table 3 shows the changes in pain score after 4 weeks of Theracurmin and exercise. The VAS was significantly decreased after 4
weeks (P<0.001). WOMAC score was significantly decreased in
pain (P<0.001), physical function difficulties (P<0.01), and total
score (P<0.01). There was no correlation between time and group.

Post

T
T+E

4.71± 1.05
4.13± 0.72
4.32± 0.88
4.35± 1.33

4.63± 0.83 Time 0.000***
4.14± 0.72 Group 0.909
T× G 0.697
6.32± 9.37 Time 0.631
3.65± 0.67 Group 0.326
T× G 0.321

Values are presented as mean± standard deviation.
T, Theracurmin intake; T+E, Theracurmin with exercise.
**P< 0.01. ***P< 0.001.

The changes in ROM of the knee
Table 4 shows the changes in ROM of the knee after 4 weeks of
Table 5. The changes of balance after treatment
Variable

Group

Pre

Post

T
T+E

53.47± 14.98
53.21± 14.89

54.38± 13.13
57.71± 8.27

One-leg with closed eyes (sec)

T
T+E

8.37± 7.47
11.73± 15.53

17.85± 16.79
14.73± 19.22

COP with open eyes (mm)

T
T+E

2,113.49± 295.29
1,766.78± 826.30

COP with closed eyes (mm)

T
T+E

1,483.45± 1,750.88
694.34± 855.78

T
T+E

55.89± 12.46
52.59± 18.44

54.78± 11.11
58.39± 5.79

One-leg with closed eyes (sec)

T
T+E

13.32± 17.02
13.32± 15.91

10.72± 9.28
17.06± 19.06

COP with open eyes (mm)

T
T+E

1,973.89± 399.00
1,754.58± 722.93

COP with closed eyes (mm)

T
T+E

1,166.72± 1,043.09
952.79± 1,011.25

More-pain site
One-leg with open eyes (sec)

Less-pain site
One-leg with open eyes (sec)

Sig

1,392.79± 423.50
1,557.48± 736.27
958.32± 1,409.48
467.68± 441.16

1,674.17± 476.55
1,583.29± 642.03
397.59± 220.48
372.33± 378.48

Time
Group
T× G
Time
Group
T× G
Time
Group
T× G
Time
Group
T× G

0.470
0.684
0.630
0.139
0.979
0.434
0.006**
0.666
0.106
0.002**
0.186
0.181

Time
Group
T× G
Time
Group
T× G
Time
Group
T× G
Time
Group
T× G

0.447
0.970
0.265
0.912
0.508
0.458
0.090
0.423
0.635
0.002**
0.608
0.639

Values are presented as mean± standard deviation.
COP, centers of pressure; T, Theracurmin intake; T+E, Theracurmin with exercise.
**P< 0.01.
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Theracurmin and exercise. The angle of flexion and extension in
more-pain site and less-pain site was decreased after 4 weeks (P<
0.001), however there was no correlation between time and group.
The changes in balance
Table 5 shows the changes in balance after 4 weeks of Theracurmin and exercise. The time of one leg standing with and without
eyes closed was not significantly different in more-pain site, COP
with closed eye was decreased after 4 weeks (P<0.01). COP with
closed eye in less-pain site was significantly decreased after 4 weeks
(P<0.01).

The changes in walking
Table 6 shows the changes in walking after 4 weeks of Theracurmin and exercise. 10-m walking speed (P<0.001), gravity
(P<0.01), and stair ascending speed (P<0.001) were significantly
decreased after treatment.
The changes in isokinetic strength
Table 7 shows the changes in isokinetic strength after 4 weeks
of Theracurmin and exercise. The muscle strength of more-pain
site was significantly increased for peak torque and total work for
both flexion and extension (P<0.01). Total work in extension shows
correlation between time and group (P=0.057). The muscle strength

Table 7. The changes of isokinetic strength after treatment
Variable
More-pain site
Flexion
Peak torque (Nm)

Work (Watt)

Extension
Peak torque (Nm)

Work (Watt)

Less-pain site
Flexion
Peak torque (Nm)

Work (Watt)

Extension
Peak torque (Nm)

Work (Watt)

Group

Pre

Post

T
T+E

29.58± 8.12
30.75± 14.51

37.33± 9.84
40.50± 17.42

T
T+E

156.67± 47.21
156.67± 85.26

184.08± 53.25
200.67± 95.29

T
T+E

68.75± 14.96
70.25± 22.49

75.42± 14.30
75.42± 23.68

T
T+E

361.33± 84.89
349.25± 151.45

375.50± 69.52
415.67± 136.77

T
T+E

28.83± 7.22
28.83± 17.22

35.67± 9.70
37.92± 19.51

T
T+E

152.92± 42.17
162.75± 100.26

178.00± 46.75
196.25± 105.89

T
T+E

75.00± 17.37
90.08± 82.76

81.25± 18.42
106.92± 99.05

T
T+E

388.92± 88.20
347.33± 152.39

384.33± 85.06
409.67± 120.23

Sig

Time
Group
T× G
Time
Group
T× G

0.000***
0.666
0.608
0.001**
0.933
0.214

Time
Group
T× G
Time
Group
T× G

0.001**
0.843
0.980
0.005**
0.760
0.057†

Time
Group
T× G
Time
Group
T× G

0.000***
0.651
0.773
0.001**
0.660
0.594

Time
Group
T× G
Time
Group
T× G

0.000***
0.454
0.075
0.102
0.854
0.061†

Values are presented as mean± standard deviation.
T, Theracurmin intake; T+E, Theracurmin with exercise.
**P< 0.01. ***P< 0.001. †Trend for significant.

https://doi.org/10.12965/jer.1735064.532

http://www.e-jer.org

689

Shin YA, et al. • Effect of theracurmin and exercise on pain and walking ability in osteoarthritis

of less-pain site was significantly increased for peak torque (P<0.001),
total work in flexion (P<0.01), and peak torque in extension (P<
0.001). The total work in extension shows correlation between time
and group (P=0.061).

DISCUSSION
This study was investigated the Theracurmin intake in conjunction with exercise effects on pain, muscular function and daily
living functions in osteoarthritis patients. The results showed that
both T and T+E groups showed improvements on all the investigated elements, and the difference between groups only observed
in the total work amount during extension of the muscle.
The major symptoms for osteoarthritis patients are pain, and
joint stiffness that decreases movement caused by limits the patient’s capacity for daily activities (Altman, 1991). Therefore, the
priority for the symptom management of osteoarthritis patients
must be pain control via drug treatment or nondrug treatment
(Bruyère et al., 2014; Fernandes et al., 2013; McAlindon et al.,
2014). However, because current long-term drug treatments can
have side effects, most studies conducted on disease modifying
agents. Curcumin is one such disease-modifying agent and known
to have an anti-inflammatory property that suppresses prostaglandin synthesis by affecting cyclooxygenase, an enzyme important
for converting arachidonic acid to prostaglandins (Rao, 2007). It
has been reported that curcumin is a catabolic mediator that inhibits inflammation by suppressing nuclear factor-kappa B activation, a key event in chronic inflammatory response (Buhrmann et
al., 2010). In this study, pain score (VAS scale) as well as pain,
function, and total scores in the WOMAC score were decreased in
both, the T and T+E groups with a 4-week intake of Theracurmin, which has a 27-fold increased physiologic activity compared
to curcumin. Although there was no significant improvement
shown in joint stiffness in WOMAC score, the range of motion of
the knee joint improved in both flexion and extension.
It proposed that these positive changes were the result of the effect of Theracurmin intake that reduced pain and discomfort from
osteoarthritis. Furthermore, aerobic and weight exercise is one of
the most strongly recommended treatments among the nondrug
treatment options for osteoarthritis (Hochberg et al., 2012), and
has been shown to be effective in decreasing discomfort due to the
pain of osteoarthritis (Juhl et al., 2014). Therefore, use of both
Theracurmin and exercise can be propose to be effective in decreasing pain and enhancing joint function.
According to previous studies, pain due to osteoarthritis and
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joint movement disorders seem to cause reduction in muscular
strength of quadriceps femoris muscle as well as loss of sensation
and proprioception (Hassan et al., 2001; Wegener et al., 1997).
Balance is a collaborative response of maintaining sensory information transmitted from vestibular organs and visual and somato
sensory organs through neurologic and muscular response from
the central nerve system (Koceja et al., 1999), and reduction in
proprioception for osteoarthritis patients can limit physical activities such as walking or balancing (van der Esch et al., 2007). As a
result of Theracurmin intake with and without exercise for 4 weeks,
there was no increase in the time for standing on one foot, but the
degree of shaking in the center of gravity while standing on one
foot both, with eyes open and closed had significantly improved.
In addition, the performance in the 10-m walking test and while
walking up the stairs improved. This suggests that the Theracurmin and exercise treatments helped decrease shaking of the patient’s center of gravity by reducing pain. In addition, the reduced
pain effect to increase the daily steps during the 4 weeks of treatment, thereby enhancing the capabilities of the 10-m walk and
walking up the stairs. However, improvements in movement and
walking ability were equivalent in both groups of Theracurmin
only and Theracurmin with exercise. This was likely because the
treatment period was relatively short to reveal the effect of exercise, and because both groups showed increased daily steps.
It has been reported that pain in the knee joint also affects muscular strength. Messier et al. (2002) reported that the muscular
strength of the quadriceps femoris muscle is lower in a group of
patients with chronic pain than in a group of patients without
chronic pain. It has also been reported that when pain in the knee
joint is decreased using local anesthetics quadriceps femoris muscular strength is significantly increased (Hassan et al., 2002). Kim
et al. (2013) reported that a significant difference was seen when
comparing more pain sites and less pain sites for knee joint extension but not for knee joint flexion. In this study, in terms of muscular strength, both, the peak torque and total work improved in
flexion and extension; the T+E group displayed more improvement than the T group during extension, showing correlation between the group and the treatment. On lesser pain sites, both, the
peak torque and total work increased during flexion, but only the
peak torque increased during extension, and the total work increased in only the T+E group, with group treatment correlation
as demonstrated in the previous studies.
Pain in the knee joint causes reflex muscle inhibition that makes
pushing the isokinetic instrument more difficult during the muscular strength measurement, decreases the activity of the quadrihttps://doi.org/10.12965/jer.1735064.532
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ceps femoris muscle, and therefore weakens the extension muscle
(Sahin et al., 2008). Therefore, we propose that pain reduction of
the knee joint from Theracurmin intake must have caused an increase in muscular strength. In addition, it has been reported that
aerobic exercise and weight training for the quadriceps femoris
muscle are effective in decreasing pain and movement disorder of
osteoarthritis patients (Juhl et al., 2014). We propose that T+E
exercise group showed more improvements than T group caused
by aerobic exercise and weight training is strengthen the quadriceps femoris, hamstring muscle, and triceps muscle of calf.
In conclusion, the 4-week intake of Theracurmin with and without exercise appeared to be effective in reducing the pain and enhancing muscular and balancing function. Although no difference
observed between the two groups except for muscular strength,
the effects of exercise depend on its intensity and duration. In addition, as reported previously, the longer the exercise period, higher the improvement (Fernandes et al., 2013). Therefore, increasing
the exercise period duration would expected to further alleviate
the symptoms of osteoarthritis compared to Theracurmin intake
without exercise. Therefore, Theracurmin intake for early symptoms and additional exercise as symptoms alleviate might be an
effective way of delaying and managing osteoarthritis, and additional studies investigating the effects of Theracurmin and exercise on osteoarthritis could be beneficial.
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